State of Alaska Department of Revenue Increases Stock Position in U.S. Physical Therapy, Inc. $USPH

State of Alaska Department of Revenue lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,039 shares of the company’s stock after buying an additional 675 shares during the quarter. State of Alaska Department of Revenue owned about 0.06% of U.S. Physical Therapy worth $706,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of USPH. Wealth Enhancement Advisory Services LLC increased its holdings in U.S. Physical Therapy by 9.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,267 shares of the company’s stock worth $290,000 after acquiring an additional 288 shares during the period. GAMMA Investing LLC increased its holdings in U.S. Physical Therapy by 27,856.8% during the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company’s stock worth $890,000 after acquiring an additional 12,257 shares during the period. Rhumbline Advisers increased its holdings in U.S. Physical Therapy by 3.5% during the 1st quarter. Rhumbline Advisers now owns 53,256 shares of the company’s stock worth $3,854,000 after acquiring an additional 1,794 shares during the period. Harbor Capital Advisors Inc. increased its holdings in U.S. Physical Therapy by 3.9% during the 1st quarter. Harbor Capital Advisors Inc. now owns 16,978 shares of the company’s stock worth $1,229,000 after acquiring an additional 634 shares during the period. Finally, Fifth Third Bancorp increased its holdings in U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock worth $75,000 after acquiring an additional 265 shares during the period.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. Barrington Research upped their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a report on Friday, August 8th. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a report on Thursday, September 18th. They set an “overweight” rating and a $110.00 target price on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Saturday, September 27th. Finally, Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Price Performance

USPH stock opened at $90.08 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $101.19. The firm’s fifty day moving average is $82.65 and its 200 day moving average is $77.05. The firm has a market cap of $1.37 billion, a P/E ratio of 39.34, a P/E/G ratio of 4.49 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same quarter last year, the firm earned $0.73 EPS. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. Research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were issued a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.0%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 78.60%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,792 shares of the stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the transaction, the chief operating officer owned 22,246 shares of the company’s stock, valued at approximately $1,925,836.22. This trade represents a 7.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 698 shares of the stock in a transaction on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the transaction, the chief financial officer directly owned 27,808 shares in the company, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,853 shares of company stock worth $581,406 in the last 90 days. Corporate insiders own 2.00% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.